Logo

FTV

Fortive Corporation

FTV

Fortive Corporation NYSE
$53.48 0.58% (+0.31)

Market Cap $18.13 B
52w High $62.79
52w Low $45.50
Dividend Yield 0.24%
P/E 21.06
Volume 1.26M
Outstanding Shares 339.07M

Income Statement

Period Revenue Operating Expense Net Income Net Profit Margin Earnings Per Share EBITDA
Q3-2025 $1.027B $489.6M $55M 5.355% $0.17 $214M
Q2-2025 $1.519B $632.5M $166.6M 10.969% $0.49 $361.6M
Q1-2025 $1.474B $620.3M $171.9M 11.661% $0.5 $368.3M
Q4-2024 $1.62B $666.2M $208.8M 12.887% $0.61 $442.6M
Q3-2024 $1.535B $623.9M $221.6M 14.44% $0.63 $405M

Balance Statement

Period Cash & Short-term Total Assets Total Liabilities Total Equity
Q3-2025 $430.8M $11.887B $5.383B $6.504B
Q2-2025 $1.833B $18.244B $7.855B $10.382B
Q1-2025 $892.1M $17.137B $6.894B $10.236B
Q4-2024 $813.3M $17.016B $6.821B $10.189B
Q3-2024 $811.3M $17.454B $6.892B $10.555B

Cash Flow Statement

Period Net Income Cash From Operations Cash From Investing Cash From Financing Net Change Free Cash Flow
Q3-2025 $55M $138.6M $-28.4M $-1.532B $-1.402B $127.3M
Q2-2025 $166.6M $311.2M $-24.6M $650.3M $940.6M $274.5M
Q1-2025 $171.9M $241.7M $-26.2M $-141M $78.8M $215M
Q4-2024 $208.8M $502.2M $3.8M $-496M $2M $465.2M
Q3-2024 $221.6M $459M $-17.6M $-281.6M $167.2M $431.2M

Revenue by Products

Product Q4-2024Q1-2025Q2-2025Q3-2025
Advanced Healthcare Solutions
Advanced Healthcare Solutions
$340.00M $300.00M $320.00M $330.00M
Intelligent Operating Solutions
Intelligent Operating Solutions
$710.00M $670.00M $680.00M $700.00M
Precision Technologies
Precision Technologies
$0 $500.00M $520.00M $0

Five-Year Company Overview

Income Statement

Income Statement Fortive’s income statement shows a business that has grown steadily over the past five years, with revenue rising each year and operating profit improving along the way. Gross and operating margins look healthy and have generally trended better over time, which suggests good cost discipline and pricing power. However, net income and earnings per share are a bit bumpier: there was an unusually strong profit year earlier in the period, followed by more normal, but flatter, earnings despite higher sales. That pattern points to some mix of one‑time items and higher expenses (such as investment in software, R&D, or deal activity) weighing on the bottom line recently, even as the core operations continue to strengthen.


Balance Sheet

Balance Sheet The balance sheet looks solid and relatively conservative. Total assets have been broadly stable with a gentle upward drift, while shareholders’ equity has increased over time, indicating that value is being built rather than eroded. Debt has edged down from earlier peak levels, which reduces financial risk, although it still represents a meaningful, but manageable, part of the capital structure. Cash levels move around from year to year, likely reflecting acquisitions and other capital decisions, but the company does not appear overextended. Overall, the balance sheet supports ongoing investment and bolt‑on deals without looking strained.


Cash Flow

Cash Flow Fortive’s cash flow profile is a key strength. Cash generated from day‑to‑day operations has grown steadily and comfortably exceeds what the company spends to maintain and expand its asset base. Capital spending is modest relative to operating cash flow, so free cash flow is strong and consistently positive. This “asset‑light” profile is what you would expect from a business shifting toward software, services, and high‑value instrumentation. The robust free cash flow gives Fortive considerable flexibility to fund acquisitions, pay down debt, and return capital, if it chooses, while still investing in innovation.


Competitive Edge

Competitive Edge Fortive holds a strong competitive position built around specialized, mission‑critical products and deeply embedded software and services. Brands like Fluke, Accruent, Industrial Scientific, ASP, and Censis serve professional users in safety, healthcare, facilities, and test and measurement—areas where reliability, compliance, and uptime matter more than price. This creates high switching costs and sticky customer relationships. The Fortive Business System underpins a culture of continuous improvement and efficient integration of acquired companies, which is difficult for rivals to copy. The recent spin‑off of its Precision Technologies segment sharpens the focus on higher‑growth, more recurring revenue businesses. Key risks include intense competition in industrial software and analytics, ongoing execution demands in M&A, and sensitivity to industrial and healthcare capital spending cycles.


Innovation and R&D

Innovation and R&D Innovation at Fortive is less about big single products and more about systems, software, and data. The Fortive Business System, “The Fort” innovation hub, and a formal Growth Accelerator program support a steady flow of new ideas and fast experimentation. Across the portfolio, the company is embedding AI, analytics, and connectivity into tools and workflows—examples include connected test instruments from Fluke, AI‑assisted hospital instrument management at Censis, data‑driven facilities software at Accruent, and advanced low‑temperature sterilization systems at ASP. A growing share of revenue now comes from software and subscriptions, which can be more predictable but also requires constant updating and cybersecurity vigilance. Future upside depends on how well Fortive can expand its SaaS and analytics platforms, keep integrating hardware and software into seamless “connected workflows,” and continue sourcing bolt‑on acquisitions that enhance its technology stack.


Summary

Taken together, Fortive looks like a steadily growing industrial technology platform with an increasing tilt toward software, data, and recurring revenue. The income statement shows healthy top‑line growth and improving core margins, while the balance sheet and cash flows indicate a financially disciplined company with strong free‑cash‑generation capacity. Its competitive edge rests on trusted brands, mission‑critical use cases, and a well‑honed operating system for continuous improvement and M&A integration. At the same time, earnings have been somewhat uneven due to one‑offs and investment, and the strategy depends on continued successful innovation, integration of acquisitions, and navigating competitive and macroeconomic cycles. Future performance will depend on how effectively Fortive can scale its connected workflow solutions and maintain its technological and operational edge in both industrial and healthcare markets.